NL129020C - - Google Patents

Info

Publication number
NL129020C
NL129020C NL129020DA NL129020C NL 129020 C NL129020 C NL 129020C NL 129020D A NL129020D A NL 129020DA NL 129020 C NL129020 C NL 129020C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL129020C publication Critical patent/NL129020C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL129020D 1964-12-15 NL129020C (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1616164A CH451945A (de) 1964-12-15 1964-12-15 Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren

Publications (1)

Publication Number Publication Date
NL129020C true NL129020C (cg-RX-API-DMAC10.html)

Family

ID=4414930

Family Applications (2)

Application Number Title Priority Date Filing Date
NL129020D NL129020C (cg-RX-API-DMAC10.html) 1964-12-15
NL6516326A NL6516326A (cg-RX-API-DMAC10.html) 1964-12-15 1965-12-15

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6516326A NL6516326A (cg-RX-API-DMAC10.html) 1964-12-15 1965-12-15

Country Status (14)

Country Link
US (1) US3361749A (cg-RX-API-DMAC10.html)
AT (1) AT256854B (cg-RX-API-DMAC10.html)
BE (1) BE673707A (cg-RX-API-DMAC10.html)
BR (1) BR6575691D0 (cg-RX-API-DMAC10.html)
CH (1) CH451945A (cg-RX-API-DMAC10.html)
DE (1) DE1545978A1 (cg-RX-API-DMAC10.html)
DK (1) DK117835B (cg-RX-API-DMAC10.html)
ES (1) ES320729A1 (cg-RX-API-DMAC10.html)
FI (1) FI45048C (cg-RX-API-DMAC10.html)
FR (2) FR1469035A (cg-RX-API-DMAC10.html)
GB (1) GB1132244A (cg-RX-API-DMAC10.html)
IL (1) IL24797A (cg-RX-API-DMAC10.html)
NL (2) NL6516326A (cg-RX-API-DMAC10.html)
NO (1) NO117424B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448083A (de) * 1963-05-04 1967-12-15 Ciba Geigy Verwendung von neuen Hydroxyaryl-pyrimidinen bei Verfahren zum Schützen von nicht-textilen organischen Materialien
CA2406562C (en) * 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Hiv replication inhibiting pyrimidines and triazines
GB0206215D0 (en) * 2002-03-15 2002-05-01 Novartis Ag Organic compounds
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
ATE542801T1 (de) 2003-08-15 2012-02-15 Novartis Ag Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
CA2626789A1 (en) * 2005-10-21 2007-04-26 Exelixis, Inc. Pyrimidinones as casein kinase ii (ck2) modulators
EA019941B1 (ru) 2006-12-08 2014-07-30 АйАрЭм ЭлЭлСи Соединения и композиции в качестве ингибиторов протеинкиназы
LU92852B1 (en) 2015-10-20 2017-05-02 Athanasios Spathis NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971307A (en) * 1961-03-02 1964-09-30 Wellcome Found 5-anilinopyrimidines

Also Published As

Publication number Publication date
GB1132244A (en) 1968-10-30
FI45048B (cg-RX-API-DMAC10.html) 1971-11-30
BR6575691D0 (pt) 1973-09-06
BE673707A (cg-RX-API-DMAC10.html) 1966-04-01
FR1469035A (fr) 1967-02-10
DK117835B (da) 1970-06-08
CH451945A (de) 1968-05-15
US3361749A (en) 1968-01-02
FR5213M (cg-RX-API-DMAC10.html) 1967-07-03
NO117424B (cg-RX-API-DMAC10.html) 1969-08-11
FI45048C (fi) 1972-03-10
IL24797A (en) 1969-11-12
ES320729A1 (es) 1966-05-16
NL6516326A (cg-RX-API-DMAC10.html) 1966-06-16
AT256854B (de) 1967-09-11
DE1545978A1 (de) 1969-12-11

Similar Documents

Publication Publication Date Title
FI45048B (cg-RX-API-DMAC10.html)
AU442366B2 (cg-RX-API-DMAC10.html)
BE658949A (cg-RX-API-DMAC10.html)
BE642735A (cg-RX-API-DMAC10.html)
BE642588A (cg-RX-API-DMAC10.html)
BE642974A (cg-RX-API-DMAC10.html)
BE47396A (cg-RX-API-DMAC10.html)
BE628611A (cg-RX-API-DMAC10.html)
BE642367A (cg-RX-API-DMAC10.html)
BE651306A (cg-RX-API-DMAC10.html)
BE610935A (cg-RX-API-DMAC10.html)
BE642104A (cg-RX-API-DMAC10.html)
BE642437A (cg-RX-API-DMAC10.html)
BE613833A (cg-RX-API-DMAC10.html)
BE627931A (cg-RX-API-DMAC10.html)
BE659811A (cg-RX-API-DMAC10.html)
BE518974A (cg-RX-API-DMAC10.html)
BE642458A (cg-RX-API-DMAC10.html)
BE637777A (cg-RX-API-DMAC10.html)
BE483969A (cg-RX-API-DMAC10.html)
BE659340A (cg-RX-API-DMAC10.html)
BE660091A (cg-RX-API-DMAC10.html)
BE642654A (cg-RX-API-DMAC10.html)
BE627057A (cg-RX-API-DMAC10.html)
BE659205A (cg-RX-API-DMAC10.html)